Session Track · IDC 2027

Dermatological Drug Delivery at IDC 2027

Part of the IDC 2027 scientific programme · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Dermatological Drug Delivery Session

Dermatological Drug Delivery refers to the science and technology of administering medications and therapeutic agents to the skin for the treatment of various dermatological conditions. It encompasses a wide range of delivery systems and strategies designed to optimize drug absorption, distribution, and efficacy while minimizing side effects and improving patient compliance. Topical formulations are the most common method of dermatological drug delivery, including creams, ointments, gels, lotions, foams, and sprays. These formulations allow drugs to penetrate the skin barrier and exert their effects locally, targeting specific skin conditions such as acne, eczema, psoriasis, and fungal infections. Transdermal drug delivery systems deliver medications through the skin and into the bloodstream, providing systemic effects. Transdermal patches, for example, deliver drugs continuously over an extended period, offering advantages such as convenience, steady drug levels, and reduced gastrointestinal side effects. Nanotechnology has revolutionized dermatological drug delivery, enabling the development of nanoparticles, liposomes, and other nanocarriers that enhance drug stability, solubility, and penetration into the skin. These nanocarriers can encapsulate drugs, protect them from degradation, and facilitate targeted delivery to specific skin layers or cells. Microneedle technology involves the use of microscopic needles to create pathways through the skin, allowing drugs to penetrate more deeply and efficiently. This approach is particularly useful for delivering large molecules, such as peptides and proteins, which may have limited skin penetration on their own. Innovations in dermatological drug delivery continue to improve treatment outcomes and patient satisfaction by enhancing drug bioavailability, minimizing side effects, and optimizing convenience and compliance. Research in this field focuses on developing novel delivery systems, improving drug stability and targeting, and exploring personalized approaches to dermatologic therapy.

Featured Speakers — Dermatological Drug Delivery 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Dermatological Drug Delivery Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Dermatological Drug Delivery Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Dermatological Drug Delivery work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Dermatological Drug Delivery research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same programme, same certificate.

Join IDC 2027 for the Dermatological Drug Delivery track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Dermatological Drug Delivery Conference 2027 — FAQs

What is the Dermatological Drug Delivery track at IDC 2027?

The Dermatological Drug Delivery track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Dermatological Drug Delivery. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Dermatological Drug Delivery sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Dermatological Drug Delivery are all welcome — whether presenting or attending.

Can I present my research in the Dermatological Drug Delivery track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Dermatological Drug Delivery sessions?

Yes. IDC 2027 is a hybrid conference — attend the Dermatological Drug Delivery track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.